Evolus Inc (FRA:EVL)
€ 15.2 0.4 (2.7%) Market Cap: 952.15 Mil Enterprise Value: 982.57 Mil PE Ratio: 0 PB Ratio: 53.62 GF Score: 52/100

Evolus Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 06:15PM GMT
Release Date Price: €10.43 (+11.00%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good afternoon, everyone. My name is Balaji Prasad. I lead the specialty pharma coverage for Barclays. And thank you for dialing into the Barclays Global Healthcare Conference. Today is Day 2. And continuing the specialty pharma track of the conference, I'm pleased to introduce the management of Evolus to you. So we have with us today David Moatazedi, President and CEO; Lauren Silvernail, CFO and VP; and Ashwin, VP Finance in the conference room. So as we look at Evolus now, David, Lauren, you've reached that pivotal point with -- setting aside the legal, there's overhangs in the past. And so I would presume I want to start with your priorities now, how do you look at business now and start with few introductory comments?

David Moatazedi
Evolus, Inc. - President, CEO & Director

Sure, Balaji. Firstly, thank you for having us on the conference. It's a pleasure to be here. And for us, it's nice to actually be in a conference room all together again, and I know you probably feel the same. It's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot